These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32962964)

  • 1. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study.
    Marin-Alejandre BA; Abete I; Monreal JI; Elorz M; Benito-Boillos A; Herrero JI; Navarro-Blasco I; Tur JA; Bandarra NM; Zulet MA; Martinez JA
    J Clin Lipidol; 2020; 14(6):837-849.e2. PubMed ID: 32962964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study.
    Chen ZY; Liu M; Jing LP; Xiao ML; Dong HL; Chen GD; Chen YM
    Eur J Nutr; 2020 Apr; 59(3):941-951. PubMed ID: 30937580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial.
    Marin-Alejandre BA; Cantero I; Perez-Diaz-Del-Campo N; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Abete I; Zulet MA
    Liver Int; 2021 Jul; 41(7):1532-1544. PubMed ID: 33550706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
    Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
    Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology.
    Khadge S; Sharp JG; Thiele GM; McGuire TR; Klassen LW; Duryee MJ; Britton HC; Dafferner AJ; Beck J; Black PN; DiRusso CC; Talmadge J
    J Nutr Biochem; 2018 Feb; 52():92-102. PubMed ID: 29175671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
    Perez-Diaz-Del-Campo N; Marin-Alejandre BA; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Abete I; Zulet MA
    Eur J Nutr; 2021 Sep; 60(6):3043-3057. PubMed ID: 33474638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD.
    Tutino V; De Nunzio V; Caruso MG; Bonfiglio C; Franco I; Mirizzi A; De Leonardis G; Cozzolongo R; Giannuzzi V; Giannelli G; Notarnicola M; Osella AR
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30217048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
    Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
    Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD).
    Maciejewska D; Marlicz W; Ryterska K; Banaszczak M; Jamioł-Milc D; Stachowska E
    Can J Gastroenterol Hepatol; 2018; 2018():5856201. PubMed ID: 30631760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss induced by a hypocaloric diet with or without fish oil supplementation re-established iron and omega-3 fatty acid homeostasis in middle-aged women with obesity: A post-hoc analysis of a randomized controlled trial.
    Huang SY; Mayasari NR; Tung TH; Lin WL; Tseng SH; Chang CC; Huang HY; Chang JS
    Maturitas; 2024 Jun; 184():107948. PubMed ID: 38447232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
    Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
    Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats.
    Tu WC; Mühlhäusler BS; Yelland LN; Gibson RA
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):53-60. PubMed ID: 22521090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
    Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
    Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between erythrocyte membrane n-3 and n-6 polyunsaturated fatty acids and carotid atherosclerosis: A prospective study.
    Ding D; Zhong QW; Zuo LS; Ling CW; Xiong F; Ke YB; Chen YM
    Atherosclerosis; 2020 Apr; 298():7-13. PubMed ID: 32126389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
    Cao J; Schwichtenberg KA; Hanson NQ; Tsai MY
    Clin Chem; 2006 Dec; 52(12):2265-72. PubMed ID: 17053155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease.
    Amirkalali B; Sohrabi MR; Esrafily A; Jalali M; Gholami A; Hosseinzadeh P; Keyvani H; Shidfar F; Zamani F
    Indian J Med Res; 2018 Apr; 147(4):352-360. PubMed ID: 29998870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.